Rifampicin improves neuronal apoptosis in LPS-stimulated co-cultured BV2 cells through inhibition of the TLR-4 pathway

Molecular Medicine Reports

Volumn 10, Issue 4, 2014, Pages 1793-1799

  Bi, Wei ^a   Zhu, Lihong ^a   Jing, Xiuna ^b   Zeng, Zhifen ^b   Liang, Yanran ^b   Xu, Anding ^a   Liu, Jun ^b   Xiao, Songhua ^b   Yang, Lianhong ^b   Shi, Qiaoyun ^c   Guo, Li ^a   Tao, Enxiang ^b  

^a JINAN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Microglia; Neuroinflammation; Neuroprotection; Rifampicin; TLR 4

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NEUROPROTECTIVE AGENT; RIFAMPICIN; TOLL LIKE RECEPTOR 4;

ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL CULTURE; COCULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; MICROGLIA; MOUSE; NERVE CELL; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; CELLS, CULTURED; COCULTURE TECHNIQUES; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; NF-KAPPA B; RATS, SPRAGUE-DAWLEY; RIFAMPIN; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84924220036     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2480     Document Type: Article

References (32)

1. Zhang H, Wang FW, Yao LL and Hao AJ: Microglia - friend or foe. Front Biosci (Schol Ed) 3: 869-883, 2011.
2. Smith JA, Das A, Ray SK and Banik NL: Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 87: 10-20, 2012.
3. Bernardi A, Frozza RL, Meneghetti A, et al: Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by Aβ1-42 in Alzheimer's disease models. Int J Nanomedicine 7: 4927-4942, 2012.
4. Sung YH, Kim SC, Hong HP, et al: Treadmill exercise ameliorates dopaminergic neuronal loss through suppressing microglial activation in Parkinson's disease mice. Life Sci 91: 1309-1316, 2012.
5. Dibaj P, Zschüntzsch J, Steffens H, et al: Influence of methylene blue on microglia-induced inflammation and motor neuron degeneration in the SOD1(G93A) model for ALS. PLoS One 7: e43963, 2012.
6. Yulug B, Kilic U, Kilic E and Bähr M: Rifampicin attenuates brain damage in focal ischemia. Brain Res 996: 76-80, 2004. (Pubitemid 37510296)
7. Paunescu E: In vivo and in vitro suppression of humoral and cellular response by rifampicin. Nature 228: 1188-1189, 1970.
8. Nilsson BS: Rifampicin: an immunosuppressant? Lancet 2: 374, 1971.
9. Dajani BM, Canadi MS, Thompson JS and Kasik JE: Rifampicin: an immunosuppressant? Lancet 2: 1904, 1972.
10. Bi W, Zhu L, Wang C, et al: Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation. Brain Res 1395: 12-20, 2011.
11. Singer CA, Figueroa-Masot XA, Batchelor RH, et al: The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 19: 2455-2463, 1999. (Pubitemid 29162395)
12. Kiefer T, Hirt C, Schüler F, et al: Statistical analysis of results obtained by real-time PCR for improvement of absolute quantification of target sequences. Clin Lab 58: 465-470, 2012.
13. Bureau G, Longpré F and Martinoli MG: Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation. J Neurosci Res 86: 403-410, 2008. (Pubitemid 351196745)
14. Kloss CU, Bohatschek M, Kreutzberg GW and Raivich G: Effect of lipopolysaccharide on the morphology and integrin immunoreactivity of ramified microglia in the mouse brain and in cell culture. Exp Neurol 168: 32-46, 2001. (Pubitemid 32195256)
15. Namba Y, Kawatsu K, Izumi S, Ueki A and Ikeda K: Neurofibrillary tangles and senile plaques in brain of elderly leprosy patients. Lancet 340: 978, 1992.
16. Chui DH, Tabira T, Izumi S, Koya G and Ogata J: Decreased beta-amyloid and increased abnormal Tau deposition in the brain of aged patients with leprosy. Am J Pathol 145: 771-775, 1994.
17. Tomiyama T, Kaneko H, Kataoka K, et al: Rifampicin inhibits the toxicity of pre-aggregated amyloid peptides by binding to peptide fibrils and preventing amyloid-cell interaction. Biochem J 322: 859-865, 1997. (Pubitemid 27135636)
18. Tomiyama T, Shoji A, Kataoka K, et al: Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J Biol Chem 271: 6839-6844, 1996.
19. Tomiyama T, Asano S, Suwa Y, et al: Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro. Biochem Biophys Res Commun 204: 76-83, 1994. (Pubitemid 24335264)
20. Kapurniotu A: Targeting alpha-synuclein in Parkinson's disease. Chem Biol 11: 1476-1478, 2004.
21. Bradbury J: New hope for mechanism-based treatment of Parkinson's disease. Drug Discov Today 10: 80-81, 2005.
22. Oida Y, Kitaichi K, Nakayama H, et al: Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain. Brain Res 1082: 196-204, 2006.
23. +-induced apoptosis and inhibits the expression of an alpha-synuclein multimer. Brain Res 1139: 220-225, 2007.
24. Chen S, Sun Y, Zeng Z and Tao E: Rifampicin inhibits apoptosis in rotenone-induced differentiated PC12 cells by ameliorating mitochondrial oxidative stress. Neural Regen Res 5: 251-256, 2010.
25. Ozato K, Tsujimura H and Tamura T: Toll-like receptor signaling and regulation of cytokine gene expression in the immune system. Biotechniques (Suppl): 66-68, 70, 72 passim, 2002.
26. Bi W, Jing X, Zhu L, Liang Y, Liu J, Yang L, Xiao S, et al: Inhibition of 26S protease regulatory subunit 7 (MSS1) suppresses neuroinflammation. Plos One 7: e36142, 2012
27. Broad A, Jones DE and Kirby JA: Toll-like receptor (TLR) response tolerance: a key physiological 'damage limitation' effect and an important potential opportunity for therapy. Curr Med Chem 13: 2487-2502, 2006. (Pubitemid 44364151)
28. Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol 1: 135-145, 2001.
29. Brown GC and Neher JJ: Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol 41: 242-247, 2010.
30. Polazzi E and Monti B: Microglia and neuroprotection: from in vitro studies to therapeutic applications. Prog Neurobiol 92: 293-315, 2010.
31. Shie FS, Chen YH, Chen CH and Ho IK: Neuroimmune pharmacology of neurodegenerative and mental diseases. J Neuroimmune Pharmacol 6: 28-40, 2011.
32. Li Y, Liu L, Barger SW, Mrak RE and Griffin WS: Vitamin E suppression of microglial activation is neuroprotective. J Neurosci Res 66: 163-170, 2001. (Pubitemid 32912285)